STAT3 and neoplasm: In NKTCL tumor cell lines with constitutive STAT3 phosphorylation and high levels of PD-L1 expression, treatment with Stattic and a STAT3 specific antisense oligonucleotide led to decreased pSTAT3 and PD-L1 expression.